Several studies have reported increased levels of CHI3L1 protein and/or mRNA in patients with a wide spectrum of pathologies including rheumatoid arthritis, osteoarthritis (OA), giant cell arteritis and malignancies. This evidence concerns the gene CHI3L1 and arteritis.